Melanoma Vaccine: What’s the Latest? | Dana-Farber Cancer Institute
A melanoma therapeutic vaccine is a type of personalized cancer vaccine that is intended to train the immune system to fight cancer cells.
A melanoma therapeutic vaccine is a type of personalized cancer vaccine that is intended to train the immune system to fight cancer cells.
Serving as ASCO’s 60th President over the past year has been an honor and a privilege, said Lynn M. Schuchter, MD, FASCO, who will end…
Award for Outstanding Journal Article | Cancer Prevention Research | American Association for Cancer Research #aacrcontent {font-size: 16px;} .right { float: right; margin: 0 16px…
Kidney and Renal Pelvis Cancer statistics
FDA Oncology Center of Excellence has formed the OCE Equity Program. To access this subscriber-only content please log in or subscribe.If your institution has a…
While Dato-DXd numerically improved overall survival for patients with non-small cell lung cancer, the data did not show statistical significance. However, a clinically meaningful benefit…
Syed Ali Abutalib, MD, and L. Jeffrey Medeiros, MD, explore the presentation and pathology of Rosai-Dorfman disease.
This marks the only CAR T-cell therapy approved by the FDA for 4 subtypes of non-Hodgkin lymphoma.
An ASCO volunteer for nearly 30 years, Robin T. Zon, MD, FACP, FASCO, is humbled and honored to be elected ASCO’s 61st President, effective during…
Leo I. Gordon, MD, discusses the significance of the FDA approval of liso-cel for patients with relapsed/refractory mantle cell lymphoma.
Blood and bone marrow transplant innovation is increasing access to life-saving procedures for many older cancer patients.